Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples